|
Recent Developments |
|
06-FEB-19
Strides Pharma Science announced that its formulations facility (KRSG Gardens) in Bangalore which was inspected by the USFDA in August 2018 and November 2018, has received the Establishment Inspection Report (EIR), there by confirming the successful closure of the inspections.
24-DEC-18
Strides Pharma Science today announced that its step???down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received app... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2017(9) | 31-Mar-2017(12) | 31-Mar-2016(12) | | Net sales | 14234.30 | 20981.30 | 20630.70 | | Other Income | 1415.50 | 1761.90 | 1417.34 | | Total Income | 15649.80 | 22743.20 | 22048.04 | | Cost of goods sold | 14864.50 | 19475.30 | 19222.06 | | OPBDIT | 785.30 | 3267.90 | 2825.98 | | PAT | 592.90 | 1197.30 | 1610.69 | | Gross Block | - | - | - | | Equity capital | - | - | 893.46 | | EPS (Rs.) | - | - | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 5.0 | 14.4 | 12.8 | | Net margin (% of OI) | 3.8 | 5.3 | 7.3 |
|
|
Detailed Financials
|
|
|
|
|
